Modified-Release Drug Delivery Technology, Second Edition : Modified Release Drug Delivery Technology, Volume 2

• Record Nr.: UNINA9910455928003321
• Autore: Rathbone Michael J
• Pubbl/distr/stampa: New York : , : CRC Press, , 2008; ©2013
• ISBN: 0-429-09286-5; 1-4200-4526-1
• Edizione: [2nd ed.]
• Descrizione fisica: 1 online resource (727 p.)
• Collana: Drugs and the pharmaceutical sciences ; ; 184
• Altri autori (Persone): HadgraftJonathan; RobertsMichael S; LaneMajella E
• Disciplina: 615/.19
• Soggetti: Controlled release technology; Controlled release preparations; Drug delivery systems; Pharmaceutical technology; Electronic books.
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and indexes.
• Nota di contenuto: ""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulationâ€?PLAD Technology""; ""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam ; Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology""; ""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers""; ""27 LidoSiteâ€?Vyteris Iontophoretic Technology""""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery""; ""37 Phospholipids as Carriers for Vaginal Drug Delivery""""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation""; ""47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs""